Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
1.730
+0.120 (7.45%)
At close: Sep 26, 2025, 4:00 PM EDT
1.770
+0.040 (2.31%)
After-hours: Sep 26, 2025, 7:59 PM EDT
Humacyte Market Cap
Humacyte has a market cap or net worth of $274.79 million as of September 26, 2025. Its market cap has decreased by -59.54% in one year.
Market Cap
274.79M
Enterprise Value
320.72M
1-Year Change
-59.54%
Ranking
Category
Stock Price
$1.73
Market Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $274.79M, an increase of 121.05%. That is a compound annual growth rate of 17.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 274.79M | -57.71% |
| Dec 31, 2024 | 649.78M | 120.90% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | 130.74M | 5.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |